Spinal neurokin3 receptors facilitate the nociceptive flexor reflex via a pathway involving nitric oxide

[1]  D. R. Linden,et al.  Spinal neurokinin3 receptors mediate thermal but not mechanical hyperalgesia via nitric oxide , 1999, Pain.

[2]  B. Undem,et al.  Pharmacological analysis of the tachykinin receptors that mediate activation of nonadrenergic, noncholinergic relaxant nerves that innervate guinea pig trachealis. , 1998, The Journal of pharmacology and experimental therapeutics.

[3]  H. Sarau,et al.  Nonpeptide tachykinin receptor antagonists: I. Pharmacological and pharmacokinetic characterization of SB 223412, a novel, potent and selective neurokinin-3 receptor antagonist. , 1997, The Journal of pharmacology and experimental therapeutics.

[4]  R. Shigemoto,et al.  Relationship of NK3 receptor‐ immunoreactivity to subpopulations of neurons in rat spinal cord , 1997, The Journal of comparative neurology.

[5]  J. R. Slack,et al.  Tachykinin Actions on Deep Dorsal Horn Neurons In Wm: An Electrophysiological and Morphological Study in the Immature Rat , 1997, The European journal of neuroscience.

[6]  U. Pehl,et al.  Electrophysiological responses of neurons in the rat spinal cord to nitric oxide , 1997, Neuroscience.

[7]  J. Krause,et al.  Functional expression of a novel human neurokinin-3 receptor homolog that binds [3H]senktide and [125I-MePhe7]neurokinin B, and is responsive to tachykinin peptide agonists. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[8]  D. Budai,et al.  Spinal NK1 receptors contribute to the increased excitability of the nociceptive flexor reflex during persistent peripheral inflammation , 1996, Brain Research.

[9]  S. Fukuhara,et al.  Further Identification of Neurokinin Receptor Types and Mechanisms of Calcium Signaling Evoked by Neurokinins in the Murine Neuroblastoma C1300 Cell Line , 1996, Journal of neurochemistry.

[10]  P. Shughrue,et al.  In situ hybridization analysis of the distribution of neurokinin‐3 mRNA in the rat central nervous system , 1996, The Journal of comparative neurology.

[11]  P. Soubrié,et al.  Evidence for Modulation of DoDamine‐neuronal Function by Tachykinin NK3 Receptor Stimulation in Gerbil Mesencephalic Cell Cultures , 1996, The European journal of neuroscience.

[12]  S. Nakanishi,et al.  Localization of the neuromedin K receptor (NK3) in the central nervous system of the rat , 1996, The Journal of comparative neurology.

[13]  A. Fox,et al.  Receptors mediating tachykinin-evoked depolarisations of neurons in the neonatal rat spinal cord. , 1996, Acta biologica Hungarica.

[14]  P. Barnes,et al.  Characterization and autoradiographic mapping of [3H]CP96,345, a nonpeptide selective NK1 receptor antagonist in guinea pig lung , 1995, Peptides.

[15]  T. Matsumoto,et al.  Nitric oxide is a mediator of tachykinin NK3 receptor‐induced relaxation in rat mesenteric artery , 1995, British journal of pharmacology.

[16]  G. Le Fur,et al.  Neuronal NK3-receptors in guinea-pig ileum and taenia caeci: in vitro characterization by their first non-peptide antagonist, SR142801. , 1995, Life sciences.

[17]  B. Chizh,et al.  Modulation of excitatory amino acid responses by tachykinins and selective tachykinin receptor agonists in the rat spinal cord , 1995, British journal of pharmacology.

[18]  A. Prat,et al.  Characterization of the tachykinin receptors involved in spinal and supraspinal cardiovascular regulation. , 1995, Canadian journal of physiology and pharmacology.

[19]  C. Maggi,et al.  Activity of SR 142801 at peripheral tachykinin receptors. , 1995, European journal of pharmacology.

[20]  E. Burcher,et al.  Characterization of Tachykinin NK sub 2 Receptors in Human Urinary Bladder , 1995 .

[21]  R. Quirion,et al.  Neuropeptide receptors in developing and adult rat spinal cord: An in vitro quantitative autoradiography study of calcitonin gene‐related peptide, neurokinins, μ‐opioid, galanin, somatostatin, neurotensin and vasoactive intestinal polypeptide receptors , 1995, The Journal of comparative neurology.

[22]  Bentley Gn,et al.  Neurokinin actions on substantia gelatinosa neurones in an adult longitudinal spinal cord preparation , 1995 .

[23]  M. Poncelet,et al.  SR 142801, the first potent non-peptide antagonist of the tachykinin NK3 receptor. , 1994, Life sciences.

[24]  S. Snyder,et al.  Nitric oxide: a neural messenger. , 1995, Annual review of cell and developmental biology.

[25]  R. Morris,et al.  The correlation between the distribution of the NK1 receptor and the actions of tachykinin agonists in the dorsal horn of the rat indicates that substance P does not have a functional role on substantia gelatinosa (lamina II) neurons , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[26]  V. Zagorodnyuk,et al.  Tachykinin NK3 receptor mediates NANC hyperpolarization and relaxation via nitric oxide release in the circular muscle of the guinea-pig colon , 1994, Regulatory Peptides.

[27]  G. Woodruff,et al.  Characterization of tachykinin mediated increases in [Ca2+]i in Chinese hamster ovary cells expressing human tachykinin NK3 receptors. , 1994, European journal of pharmacology.

[28]  Q. Nguyen,et al.  Two NK-3 receptor subtypes: Demonstration by biological and binding assays , 1994, Neuropeptides.

[29]  T. Coderre,et al.  Intracellular Messengers Contributing to Persistent Nociception and Hyperalgesia Induced by L‐Glutamate and Substance P in the Rat Formalin Pain Model , 1994, The European journal of neuroscience.

[30]  R. Traub,et al.  The role of nitric oxide in the development and maintenance of the hyperalgesia produced by intraplantar injection of carrageenan in the rat , 1994, Neuroscience.

[31]  G. Baranauskas,et al.  Multiple types of tachykinin receptor mediate a slow excitation of rat spinal motoneurones in vitro , 1994, Neuroscience Letters.

[32]  R. Grisshammer,et al.  Expression of rat NK-2 (neurokinin A) receptor in E. coli. , 1994, Receptors & channels.

[33]  D. Stuehr,et al.  Nitric oxide synthases reveal a role for calmodulin in controlling electron transfer. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[34]  R. Hagan,et al.  Depression of primary afferent‐evoked responses by GR71251 in the isolated spinal cord of the neonatal rat , 1993, British journal of pharmacology.

[35]  J. Glowinski,et al.  A new selective bioassay for tachykinin NK3 receptors based on inositol monophosphate accumulation in the guinea pig ileum. , 1993, European journal of pharmacology.

[36]  C. Maggi,et al.  Nitric oxide is the mediator of tachykinin NK3 receptor-induced relaxation in the circular muscle of the guinea-pig ileum. , 1993, European journal of pharmacology.

[37]  S. Lavielle,et al.  A novel, selective radioligand, [125I]-[Lys5, Tyr(I2)7, Meleu9, Nle10]-NKA(4–10), for the tachykinin NK-2 receptor , 1993, Regulatory Peptides.

[38]  C. Humpel,et al.  Characterization of neurokinin binding sites in rat brain membranes using highly selective ligands , 1993, Neuropeptides.

[39]  H. Zhuo,et al.  Neurokinin B peptide-2 neurons project from the hypothalamus to the thoracolumbar spinal cord of the rat , 1993, Neuroscience.

[40]  G. Gebhart,et al.  Nitric oxide mediates the thermal hyperalgesia produced in a model of neuropathic pain in the rat , 1992, Neuroscience.

[41]  E. Kawashima,et al.  Molecular characterisation, expression and localisation of human neurokinin‐3 receptor , 1992, FEBS letters.

[42]  J. Haley,et al.  Electrophysiological evidence for a role of nitric oxide in prolonged chemical nociception in the rat , 1992, Neuropharmacology.

[43]  I. K. Wright,et al.  Characterization of tachykinin-induced ventral root depolarization in the neonatal rat isolated spinal cord , 1992, Neuroscience.

[44]  R. Hagan,et al.  Ontogeny and characterization of [125I]Bolton Hunter-Eledoisin binding sites in rat spinal cord by quantitative autoradiography , 1992, Neuroscience.

[45]  C. Maggi,et al.  On the role of NK-2 tachykinin receptors in the mediation of spinal reflex excitability in the rat , 1991, Neuroscience.

[46]  H. Fields,et al.  Evidence that inhibition of a nociceptive flexion reflex by stimulation in the rostroventromedial medulla in rats occurs at a premotoneuronal level , 1991, Brain Research.

[47]  R. Quirion,et al.  Quantitative autoradiographic distribution of multiple neurokinin binding sites in rat spinal cord , 1990, Brain Research.

[48]  M. Wienrich,et al.  Effects of receptor‐selective neurokinin agonists and a neurokinin antagonist on the electrical activity of spinal cord neurones in culture , 1989, British journal of pharmacology.

[49]  C. Maggi,et al.  Neurokinin receptors in the rat lower urinary tract. , 1988, The Journal of pharmacology and experimental therapeutics.

[50]  W. Young,et al.  Distribution of cells containing mRNAs encoding substance P and neurokinin B in the rat central nervous system , 1988, The Journal of comparative neurology.

[51]  S. Guard,et al.  Neurokinin3‐receptors are linked to inositol phospholipid hydrolysis in the guinea‐pig ileum longitudinal muscle‐myenteric plexus preparation , 1988, British journal of pharmacology.

[52]  R. Couture,et al.  Characterization of the effects produced by neurokinins and three agonists selective for neurokinin receptor subtypes in a spinal nociceptive reflex of the rat. , 1988, Life sciences.

[53]  N. Rhaleb,et al.  Characterization of neurokinin receptors in various isolated organs by the use of selective agonists. , 1987, Life sciences.

[54]  M. Devor,et al.  Behavioural effects of receptor-specific substance P agonists , 1987, Pain.

[55]  Gavin Kilpatrick,et al.  Pharmacological analysis of 125I-Bolton and Hunter labelled eledoisin binding sites in rat spinal cord by quantitative autoradiography , 1987, Neuroscience Letters.

[56]  P. Rovero,et al.  The rat isolated portal vein: a preparation sensitive to neurokinins, particularly neurokinin B. , 1987, European journal of pharmacology.

[57]  T. O'donohue,et al.  Pharmacologic characterization and autoradiographic distribution of binding sites for iodinated tachykinins in the rat central nervous system , 1986, Peptides.

[58]  C. Woolf,et al.  Substance P and calcitonin gene-related peptide synergistically modulate the gain of the nociceptive flexor withdrawal reflex in the rat , 1986, Neuroscience Letters.

[59]  Z. Wiesenfeld‐Hallin,et al.  Substance P and somatostatin modulate spinal cord excitability via physiologically different sensory pathways , 1986, Brain Research.

[60]  I. Kanazawa,et al.  Regional distribution of substance P, neurokinin α and neurokinin β in rat spinal cord, nerve roots and dorsal root ganglia, and the effects of dorsal root section or spinal transection , 1985, Brain Research.

[61]  I. Kanazawa,et al.  The excitatory action of the newly-discovered mammalian tachykinins, neurokinin α and neurokinin β, on neurons of the isolated spinal cord of the newborn rat , 1984, Neuroscience Research.

[62]  J. Glowinski,et al.  Differential localization of tachykinin receptors in rat spinal cord. , 1984, European journal of pharmacology.

[63]  S. Moochhala,et al.  Hyperalgesia produced by intrathecal substance P and related peptides: desensitization and cross desensitization , 1984, British journal of pharmacology.

[64]  J. Henry,et al.  Substance P reduces tail-flick latency: Implications for chronic pain syndromes , 1982, Pain.